BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16785989)

  • 1. Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice.
    Tsumura H; Yoshida T; Saito H; Imanaka-Yoshida K; Suzuki N
    Oncogene; 2006 Dec; 25(59):7673-9. PubMed ID: 16785989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
    Wang Y; Zhang Z; Lubet RA; You M
    Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
    Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
    Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.
    Nanni P; Nicoletti G; De Giovanni C; Croci S; Astolfi A; Landuzzi L; Di Carlo E; Iezzi M; Musiani P; Lollini PL
    Cancer Res; 2003 Jun; 63(11):2728-32. PubMed ID: 12782574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rhabdomyosarcoma development in Trp53/fos mutant mice: tumor suppressor functions of the Fos protooncogene].
    Jochum W
    Verh Dtsch Ges Pathol; 2004; 88():224-30. PubMed ID: 16892556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras.
    Lee JS; Gil JE; Kim JH; Kim TK; Jin X; Oh SY; Sohn YW; Jeon HM; Park HJ; Park JW; Shin YJ; Chung YG; Lee JB; You S; Kim H
    Biochem Biophys Res Commun; 2008 Jan; 365(3):496-502. PubMed ID: 18021740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a novel experimental system using single cell-derived pleomorphic rhabdomyosarcoma cell lines expressing K-RasG12V and deficient in p53.
    Saito H; Suzuki N
    Exp Anim; 2023 Nov; 72(4):446-453. PubMed ID: 37081671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
    Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
    Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
    Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
    Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice.
    Plowman SJ; Arends MJ; Brownstein DG; Luo F; Devenney PS; Rose L; Ritchie AM; Berry RL; Harrison DJ; Hooper ML; Patek CE
    Exp Cell Res; 2006 Jan; 312(1):16-26. PubMed ID: 16271715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Point mutations of N-ras oncogene and abnormal expression of rasp21, p53 proteins in orbital rhabdomyosarcoma].
    Zhang H; Song G; Zhang S; Chang J; Zhang W; Yu H
    Zhonghua Yan Ke Za Zhi; 2000 Jul; 36(4):267-9, 16. PubMed ID: 11853610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 family members in myogenic differentiation and rhabdomyosarcoma development.
    Cam H; Griesmann H; Beitzinger M; Hofmann L; Beinoraviciute-Kellner R; Sauer M; Hüttinger-Kirchhof N; Oswald C; Friedl P; Gattenlöhner S; Burek C; Rosenwald A; Stiewe T
    Cancer Cell; 2006 Oct; 10(4):281-93. PubMed ID: 17045206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human p53 knock-in (hupki) mice do not differ in liver tumor response from their counterparts with murine p53.
    Jaworski M; Hailfinger S; Buchmann A; Hergenhahn M; Hollstein M; Ittrich C; Schwarz M
    Carcinogenesis; 2005 Oct; 26(10):1829-34. PubMed ID: 15917304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of transcripts and proteins modulated by K-ras oncogene in the lung tissues of K-ras transgenic mice by omics approaches.
    Lee S; Kang J; Cho M; Seo E; Choi H; Kim E; Kim J; Kim H; Kang GY; Kim KP; Park YH; Yu DY; Yum YN; Park SN; Yoon DY
    Int J Oncol; 2009 Jan; 34(1):161-72. PubMed ID: 19082487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
    Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
    Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic model of cardiac rhabdomyosarcoma formation.
    Köbbert C; Möllmann C; Schäfers M; Hermann S; Baba HA; Hoffmeier A; Breithardt G; Scheld HH; Weissen-Plenz G; Sindermann JR
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1178-86. PubMed ID: 19026800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of p53 enhances the induction of colitis-associated neoplasia by dextran sulfate sodium.
    Chang WC; Coudry RA; Clapper ML; Zhang X; Williams KL; Spittle CS; Li T; Cooper HS
    Carcinogenesis; 2007 Nov; 28(11):2375-81. PubMed ID: 17557903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of spontaneous tumorigenesis in p53-knockout mice.
    Hursting SD; Perkins SN; Haines DC; Ward JM; Phang JM
    Cancer Res; 1995 Sep; 55(18):3949-53. PubMed ID: 7664260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of p53 and MCT-1 overexpression synergistically promote chromosome instability and tumorigenicity.
    Kasiappan R; Shih HJ; Chu KL; Chen WT; Liu HP; Huang SF; Choy CO; Shu CL; Din R; Chu JS; Hsu HL
    Mol Cancer Res; 2009 Apr; 7(4):536-48. PubMed ID: 19372582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.